RENTSCHLER BIOPHARMA – Together We Build

Oct 22, 2025

Together we build our new buffer media station, the largest single investment in our company’s history at our Laupheim headquarters.

Posted by Rentschler Biopharma Inc

https://www.linkedin.com/posts/rentschler-biopharma_rentschler-biopharma-new-bms-activity-7383456231018885120-QpQ-?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAAGBIr0BAP_3y98KQZnfRhIRQ-kqOWXe0fc

On October 10, we marked a major milestone: the construction progress of our new buffer media station, the largest single investment in our company’s history at our Laupheim headquarters. This project is an important contribution to strengthening the competitiveness of both Rentschler Biopharma and the biotechnology sector in Germany and Europe.
 
One highlight was the symbolic placement of a time capsule, bearing the message “Together We Build” – a symbol of shared responsibility for the future of healthcare. In a panel discussion, members of our Executive Board, together with the Managing Director of the NXTGN Startup Factory, discussed how investments and innovation are shaping future and competitiveness in the biotech sector. 
 
Our CEO Benedikt von Braunmühl commented: “At Rentschler Biopharma, we invest with foresight in infrastructure that ensures stability and sustainable growth – always keeping in mind our clients and, above all, patients worldwide. As an independent family-owned company, we have always taken a long-term, future-focused approach: We combine our strength in innovation with responsibility to ensure a sustainable future for Rentschler Biopharma. My sincere thanks go to all colleagues whose dedication and expertise have made this milestone possible.”
 
Christiane Bardroff, our COO explained: “As a CDMO, it is our responsibility to support our global clients in transforming innovative ideas into life-saving biopharmaceuticals and enabling rapid market access for new therapies. With additional capacity for buffer and media solutions, we are laying the foundation to respond flexibly to our clients’ growing needs while ensuring patients have reliable access to therapies.”
 
Dr. Michael Zyder, Managing Director of NXTGN, added: “Innovation requires reliability. Especially at a time when the future of Germany as a biotech hub is widely debated, the collaboration between Rentschler Biopharma and the NXTGN Startup Factory demonstrates what truly matters: a partnership of equals that connects novel ideas from research and start-ups with industrial implementation – strengthening Europe’s competitiveness and strategic sovereignty.”

hashtagTogetherWeBuild hashtagBiotech hashtagInnovation hashtagLaupheim hashtagRentschlerBiopharma hashtagCDMO

Download Attachment

See all Member News